- /
- Supported exchanges
- / US
- / ETBI.OTCCE
Eastgate Biotech Corp (ETBI OTCCE) stock market data APIs
Eastgate Biotech Corp Financial Data Overview
Eastgate Biotech Corp., produces and distributes nutraceuticals that are based on natural therapies and absorbed naturally by the body. The company is developing pharmaceutical products, such as Lorazepam spray for acute seizures; and EGP-1214, intraoral (sublingual) insulin tablet for diabetes and metabolic syndrome. It is also developing natural healing medication and other products, including E-drops NANO, a plant essential oil for urinary and vaginal tract infections; Essential, a Vitamin D3, to improve the body's digestive, cardiovascular, and immune systems; GluCora to lower daily intake of insulin; VCleanzz, an antibacterial wash for fruits and vegetables; Cleanezze, a natural hand sanitizer; and Warts X, a natural herbal product to treats warts. The company was formerly known as Eastgate Acquisitions Corporation and changed its name to Eastgate Biotech Corp. in December 2014. Eastgate Biotech Corp. was incorporated in 1999 and is based in Toronto, Canada.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Eastgate Biotech Corp data using free add-ons & libraries
Get Eastgate Biotech Corp Fundamental Data
Eastgate Biotech Corp Fundamental data includes:
- Net Revenue: 138 K
- EBITDA: -3 547 488
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2020-03-31
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Eastgate Biotech Corp News
New
EastGate Biotech Corp. Enters into a Licensing and Distribution Agreement for Glucora, One of Its Nutraceutical Products for the US, Canadian, Central and South American Markets
The Licensing Fee of $3 Million USD to be Paid in a Combination of Cash and Sales-Driven Funding WEST CALDWELL, NJ and TORONTO, ON, March 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – EastGate ...
EastGate Biotech Pakistan Expands its Collaboration in Advancing the Development of a New Vaccine Against COVID-19
Joint Venture Collaboration to also pursue antibiotic products to create a pipeline to fight various new strains of flu illnesses WEST CALDWELL, NJ and TORONTO, ON, Feb. 18, 2020 (GLOBE NEWSWIRE) -...
EastGate Biotech Pakistan Receives International Marketing Rights of Anaferon an Approved Coronavirus Treatment to Potentially Combat the Wuhan Coronavirus
WEST CALDWELL, NJ and TORONTO, ON, Jan. 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – EastGate Biotech Corp. (OTC: PINK: ETBI), a pharmaceutical company, that focuses on innovative technological...
EastGate Biotech Provides Summary of 2019 Corporate and Development Highlights
WEST CALDWELL, NJ and TORONTO, ON, Dec. 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – EastGate Biotech Corp. (OTC: PINK: ETBI), a pharmaceutical company that focuses on innovative technological ...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.